Nothing Special   »   [go: up one dir, main page]

DK2968227T3 - S-enantiomerberigede sammensætninger af beta-blokkere til behandling af amyotrofisk lateral sklerose - Google Patents

S-enantiomerberigede sammensætninger af beta-blokkere til behandling af amyotrofisk lateral sklerose Download PDF

Info

Publication number
DK2968227T3
DK2968227T3 DK14764992.5T DK14764992T DK2968227T3 DK 2968227 T3 DK2968227 T3 DK 2968227T3 DK 14764992 T DK14764992 T DK 14764992T DK 2968227 T3 DK2968227 T3 DK 2968227T3
Authority
DK
Denmark
Prior art keywords
sklorists
enantiomed
treatment
amyotrophic lateral
beta blockers
Prior art date
Application number
DK14764992.5T
Other languages
English (en)
Inventor
Stefan Anker
Jochen Springer
Andrew J S Coats
Original Assignee
Andrew J S Coats
Univ Berlin Charite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew J S Coats, Univ Berlin Charite filed Critical Andrew J S Coats
Application granted granted Critical
Publication of DK2968227T3 publication Critical patent/DK2968227T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14764992.5T 2013-03-14 2014-03-14 S-enantiomerberigede sammensætninger af beta-blokkere til behandling af amyotrofisk lateral sklerose DK2968227T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361786235P 2013-03-14 2013-03-14
PCT/AU2014/000274 WO2014138814A1 (en) 2013-03-14 2014-03-14 S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis

Publications (1)

Publication Number Publication Date
DK2968227T3 true DK2968227T3 (da) 2019-05-13

Family

ID=51535623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14764992.5T DK2968227T3 (da) 2013-03-14 2014-03-14 S-enantiomerberigede sammensætninger af beta-blokkere til behandling af amyotrofisk lateral sklerose

Country Status (11)

Country Link
US (4) US10449166B2 (da)
EP (1) EP2968227B1 (da)
CN (1) CN105358140A (da)
AU (1) AU2014231724B2 (da)
CA (1) CA2906206C (da)
DK (1) DK2968227T3 (da)
ES (1) ES2725893T3 (da)
HK (1) HK1220609A1 (da)
PL (1) PL2968227T3 (da)
PT (1) PT2968227T (da)
WO (1) WO2014138814A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017144977A1 (en) 2016-02-26 2017-08-31 Act Ventures Ltd. S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
HUP1800298A1 (hu) * 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
GB2593902B (en) 2020-04-07 2022-04-13 Actimed Therapeutics Ltd Salt of a pharmaceutical compound
GB202301180D0 (en) 2023-01-27 2023-03-15 Actimed Therapeutics Ltd Salt of a pharmaceutical compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4219897A (en) * 1996-09-18 1998-04-14 Daiso Co. Ltd. Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
US20050143378A1 (en) * 2003-12-29 2005-06-30 Yun Anthony J. Treatment of conditions through pharmacological modulation of the autonomic nervous system
WO2007014219A2 (en) 2005-07-25 2007-02-01 The Curavita Corporation Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis
CN101323580A (zh) * 2008-07-25 2008-12-17 河北科技大学 手性芳氧丙醇胺类化合物及其盐的合成方法
GB0907350D0 (en) 2009-04-29 2009-06-10 Myotec Therapeutics Ltd Methods
KR20150073944A (ko) * 2012-07-25 2015-07-01 싸이오서스 테라퓨틱스 엘티디. 악액질 및 근육감소증 치료를 위한 s­핀돌롤의 사용

Also Published As

Publication number Publication date
AU2014231724A1 (en) 2015-10-29
US20200054585A1 (en) 2020-02-20
PT2968227T (pt) 2019-05-30
AU2014231724B2 (en) 2018-05-10
EP2968227A1 (en) 2016-01-20
US10449166B2 (en) 2019-10-22
US11938102B2 (en) 2024-03-26
US20240325322A1 (en) 2024-10-03
CA2906206C (en) 2021-09-14
EP2968227B1 (en) 2019-02-13
ES2725893T3 (es) 2019-09-30
PL2968227T3 (pl) 2019-09-30
WO2014138814A1 (en) 2014-09-18
US20160022613A1 (en) 2016-01-28
CN105358140A (zh) 2016-02-24
CA2906206A1 (en) 2014-09-18
HK1220609A1 (zh) 2017-05-12
US20210330615A1 (en) 2021-10-28
US11007158B2 (en) 2021-05-18
NZ713051A (en) 2020-09-25
EP2968227A4 (en) 2016-10-26

Similar Documents

Publication Publication Date Title
DK3022217T3 (da) Sammensætninger til modulering af tau-ekspression
DK2984166T3 (da) Sammensætninger til behandling af mpsi
DK2970954T3 (da) Modifikation af polypeptider
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK3087183T3 (da) Modulation af angiopoietin-3-lignende ekspression
DK2968208T3 (da) Behandling af kataplexi
DK3454346T3 (da) Anordning til cylotronfremstilling af technetium-99m
DK2961766T3 (da) Kvantificering af vaccinesammensætninger
DK2961388T3 (da) Kombinationer af lægemidler
DK3068854T4 (da) Fjernelse af uønskede propanolbestanddele
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
DK3054782T3 (da) Fremgangsmåde til tørring af biomasse
DK3016991T3 (da) Sammensætninger til formning af væsker
DK2822568T3 (da) Anvendelser af caseinsammensætninger
ES2985057T3 (es) Composiciones adhesivas estructurales
DK3071670T3 (da) Integreret fremgangsmåde til fremstilling af carbonhydrider
DK2906580T3 (da) Behandling af amyotrofisk lateral sklerose
DK3027750T3 (da) Biokatalytisk sammensætning
FR3003862B1 (fr) Nouvelle composition de polyols-glycosides
DK2956443T3 (da) Hydantoiner som modulatorer af BACE-medieret APP-forarbejdning
FR3008423B1 (fr) Nouvelle souche de aurantiochytrium
DK2965026T3 (da) Generering af slushice
DK2985275T3 (da) Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre
DK3052102T3 (da) Sammensætninger til behandling af cancere
DK3071053T3 (da) Præbiotisk sammensætning